Načítá se...
Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is characterised by chronic pulmonary inflammation punctuated by periods of viral exacerbations. Recent evidence suggests that the combination of roflumilast with corticosteroids may improve the compromised anti-inflammatory properties of cort...
Uloženo v:
Vydáno v: | Respir Res |
---|---|
Hlavní autoři: | , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BioMed Central
2015
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4335416/ https://ncbi.nlm.nih.gov/pubmed/25652132 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-015-0179-5 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|